Showing 1 to 10 of 18 clinical trials
1 | 2 |
1 |
2 |
1 | 2 |
|
CLINICAL TRIALS Trial No ClinicalTrials.gov ID |
Phase | Coordinator | |
|---|---|---|---|
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169  Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL DE L'ENFANT-JESUS |
Alice Ndayizigiye 418-525-4444 poste 15782 |
|
|
Phase II Study to Assess the Safety of Non-operative Management for Low Rectal Cancer
PJT - 148730 (NOM - rectal cancer) NCT03179540 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL HOPITAL SAINT-FRANCOIS D'ASSISE |
||
|
A Proof-of-Concept Phase II Trial to Evaluate the EMT Inhibitor Sotevtamab Combined With FOLFOX Administered as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
EGIA-003 NCT06225843 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Chantal Gosselin 514-890-8000 poste 24892 |
|
|
A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.
Morpheus study (no surgery) NCT03051464 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL |
Nassima Taleb 514-890-8000 poste 10812 |
|
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CISSS DE CHAUDIERE-APPALACHES HOTEL-DIEU DE LEVIS |
Pierre Bédard 418-835-7121 |
|
|
A Pilot Study of Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in Rectal Cancer Patients.
Morpheus study (no surgery) NCT03051464 Recruiting
|
CISSS DE L'OUTAOUAIS HOPITAL DE GATINEAU |
Céline Roy 819-966-6100 poste 3669 |
|
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CISSS DE LA MONTEREGIE-CENTRE HOPITAL CHARLES-LE MOYNE |
Valérie Painchaud-Lachapelle 450-466-5000 poste 2278 |
|
|
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
CRC10 (NRG-GI008) NCT05174169 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE HOPITAL FLEURIMONT |
Michelle Roy 819-346-1110 poste 12848 |
|
|
A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer
PERIOP-01 NCT01455831 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Phase III |
Elena Shulikovsky 514-340-8222 poste 23703 |
|
A phase 2, randomized, open-label study of encorafenib and cetuximab plus pembrolizumab versus pembrolizumab alone in participants with previously untreated BRAF V600E-MUTANT, MSI H/DMMR metastatic colorectal cancer
SEAMARK NCT05217446 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Aline Mamo 514-340-8222 poste 5525 |
Groupe d'étude en oncologie du Québec